Glaucoma is one of the major eye disorder which affects the optic nerve carrying information from eye to brain. According to report from WHO Glaucoma is the second leading cause for total blindness. Traditionally topical medications and laser surgery especially trabeculotomy are principal methods to treatment glaucoma. The high risk due to complications and high cost associated with the treatment procedures have created the grounds for new safe and effective methods. Prior moving forward an accurate diagnosis is essential for the effective treatment. The Glaucoma Diagnostics offers leverage in determining the condition of intraocular pressure, optic nerve, and drainage angle. The Glaucoma Diagnostics include the Corneal Pachymeters, Optical Coherence Tomography (OCT) Imaging Systems. Which facilitate the particular outline of the glaucoma formation in the eye. The Glaucoma Diagnostics offers advantage over traditional diagnostic procedures as it decreases the probability of miss-diagnosis, it also offers preoperative benefits.
Glaucoma Diagnostics Market: Drivers and Restraints
The primary driving factor for Glaucoma Diagnostics market is raising geriatric population which is majorly affected by glaucoma. Novel technique and shorter duration of procedure is luring high numbers of end users, directly propelling the growth for the Glaucoma Diagnostics market
. The raising awareness for minimal invasive surgeries in eye disorders and increased utilization of the Glaucoma Diagnostics over the study period is anticipated to propel the growth for the Glaucoma Diagnostics market. Latest technological advancement and improved accuracy profile of the Glaucoma Diagnostics is aiding the growth of the market. Increasing adoption of Optical Coherence Tomography by Ophthalmologist and lab technicians, which is anticipated to propel the growth for the Glaucoma Diagnostics market. However, rigid reimbursement scenario for Glaucoma Diagnostics is anticipated to restrain the growth of the Glaucoma Diagnostics market
Glaucoma Diagnostics Market: Segmentation
The global Glaucoma Diagnostics market can be segmented on the basis of product type, indication type, end user, and geography.
Based on the product type, the global Glaucoma Diagnostics market is segmented as:
- Optical Coherence Tomography Imaging Systems
- Retinal Tomography and Retinal Angiography Systems
- Corneal Pachymeters
- Visual Field Testing Devices
- Open angle glaucoma
- Low tension glaucoma
- Pigmentary glaucoma
- Closed angle glaucoma
Based on the end user, the global Glaucoma Diagnostics market is segmented as:
- Specialty Clinics
- Ophthalmology Diagnostic Centers
- Research Institutes
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=4003
Glaucoma Diagnostics Market: Overview.
The global Glaucoma Diagnostics market is anticipated to show significant growth as Optical Coherence Tomography (OCT) Imaging Systems, Corneal Pachymeters, Tonometers offers greater advantage over tradition procedures for diagnosis of glaucoma. The recent advancement in the intraocular imaging technology is anticipated to offer lucrative market opportunity in the Glaucoma Diagnostics market. The recent advancement in the technological aspect of the Glaucoma Diagnostics such Disc stereo photography is expected to promote competition in the Glaucoma Diagnostics market. In the forthcoming years, the global Glaucoma Diagnostics market is anticipated to witness the entry of new market players which would increase market competition in the Glaucoma Diagnostics market. Introduction of high end cooular coherence tomography in diagnosis of open angle glaucoma is anticipated to fuel the competition in the Glaucoma Diagnostics market
Glaucoma Diagnostics Market: Regional Outlook
Geographically, the global Glaucoma Diagnostics market is segmented into regions viz. North America, Europe, East Asia, Latin America, South Asia, Middle East and Africa (MEA) and the Oceania. North America is estimated to be the dominant market in the global Glaucoma Diagnostics market owing to large number of patients opting for eye surgeries for glaucoma. Moreover, government aid in the funding for research and development in the Glaucoma Diagnostics and technology is anticipated to lead the market growth for the Glaucoma Diagnostics. The Glaucoma Diagnostics market in the East Asia and South Asia is expected to grow significantly due to the increasing healthcare spending and recent rise in healthcare standards in China and India. Europe is expected to hold a second largest share in the global Glaucoma Diagnostics market throughout the forecast period owning to the increased number of minimal invasive surgical procedure directly fueling the demand for Glaucoma Diagnostics.
Report Analysis@ https://www.factmr.com/report/4003/glaucoma-diagnostics-market
Glaucoma Diagnostics Market: Key Players
The global market for Glaucoma Diagnostics is fragmented with few number of market players. Examples of some of the key players operating in the global Glaucoma Diagnostics market are NIDEK CO., LTD, Topcon Corporation, Heidelberg Engineering GmbH, Carl Zeiss Meditec AG, Optovue Incorporated, Leica Microsystems, and Haag-Streit Group.
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative